What is LOPJLB’s current signal on INKT?

LOPJLB’s latest quantitative signal on MiNK Therapeutics, Inc. (INKT) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is INKT in?

MiNK Therapeutics, Inc. (INKT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is MiNK Therapeutics, Inc. based / listed?

MiNK Therapeutics, Inc. is based in US, listed on NASDAQ.

MiNK Therapeutics, Inc. (INKT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$10.72-2.55%Close

SELLRECOVERY · day 51

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $53M
Beta: 0.47
P/E (TTM): -4.90

Short % float: 4.15%
Days to cover: 3.1
SI change: -13.2%

1W: -13.83%
1M: -11.62%

vs SPY 1W: -14.99%
vs SPY 1M: -14.62%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and…

Employees: 15
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 5.0M
Float: 24.0%

minktherapeutics.com ↗

Key executives

Jennifer S. Buell — Co-Founder, President, CEO & Director

Terese C. Hammond — Head of Inflammatory & Pulmonary Diseases

Melissa Orilall — Principal Financial Officer

SEC filings

EDGAR · CIK 18402290 · INKT

Analyst consensus

Buy

Bullish480.0%

Neutral120.0%

Bearish00.0%

L $35.00Avg $35.00H $35.00

Target$35.00+226.49%

Last$10.72

Key stats

Prediction markets

Company news